ARTAL GROUP S A
Q3 2025 Form 13-F

LUXEMBOURG
CIK 0001053906 · Institutional investment manager
Consolidated report · includes 5 managers since Q2 2013
$758.2M Reported Value Total
Reported value
$758.2M
Quarter over quarter
-18.5%
Holdings
2
Top-10 concentration
100.0%

Reports holdings for

  • Invus Public Equities Advisors LLC · File #028-11522 · Q2 2013 – Q2 2024
  • Artal Luxembourg S A · File #028-19506 · Q1 2019 – Q1 2023
  • Artal Treasury Ltd (not a 13F filer in our records) · File #028-19088 · Q4 2018 – Q4 2021
  • Invus Advisors, L.L.C. (not a 13F filer in our records) · File #028-14596 · Q2 2013 – Q3 2013

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Anne Goffard
Authorized Person

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2025 13F record

Q3 2025 13F filing summary

Q3 2025 Form 13F portfolio summary
Period of report September 30, 2025
Filed November 12, 2025
Form 13F-HR
Reported value $758.2M
Positions 2
Change in reported value -18.5%
New positions 0
Exited positions 0
Position turnover 0.0%
Top-10 concentration 100.0%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 13, 2026
2 $931.1M
Q1 2026 13F
Filed May 14, 2026
2 $1.0B
Q4 2025 13F
Filed Feb 12, 2026
2 $714.6M
Q3 2025 13F
Filed Nov 12, 2025
2 $758.2M
Q2 2025 13F
Filed Aug 13, 2025
2 $930.2M
Q1 2025 13F
Filed May 14, 2025
2 $884.2M
Q4 2024 13F
Filed Feb 14, 2025
2 $1.2B
Q3 2024 13F
Filed Nov 13, 2024
2 $2.4B
Q2 2024 13F
Filed Aug 14, 2024
109 $3.9B
Q1 2024 13F
Filed May 13, 2024
107 $3.9B
Q4 2023 13F
Filed Feb 9, 2024
91 $3.0B
Q3 2023 13F
Filed Nov 13, 2023
101 $2.3B
Q2 2023 13F
Filed Aug 11, 2023
114 $3.2B
Q1 2023 13F
Filed May 12, 2023
118 $1.7B
Q4 2022 13F
Filed Feb 13, 2023
125 $1.8B
Q3 2022 13F
Filed Nov 14, 2022
130 $2.3B
Q2 2022 13F
Filed Aug 11, 2022
132 $1.9B
Q1 2022 13F
Filed May 12, 2022
135 $2.4B
Q4 2021 13F
Filed Feb 11, 2022
144 $3.7B
Q3 2021 13F
Filed Nov 12, 2021
140 $4.5B

33 earlier quarters on file — choose one from the quarter menu above.

Top 2 holdings · Q3 2025

Largest Q3 2025 13F positions by reported value
# Holding Reported value % of portfolio
1 CAVA Cava Group Inc $574.4M 75.75%
2 LXRX Lexicon Pharmaceuticals Inc $183.8M 24.25%

Values as reported on the Q3 2025 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings